Depo Provera May Raise STD Risks

August 23, 2004 - According to a new study, women who use the injectable contraceptive Depo Provera may be at increased risk of sexually transmitted diseases.

Researchers found that women using Depo Provera are more than three times more likely to have Chlamydia or gonorrhea within a year than women who use contraceptives or nonhormonal contraceptives.

Dr. Charles Morrison, International Research Fellow at the Research Triangle Family Health Center, says: Please use condoms. ", NC, at a press conference." Restricting the number of partners for sexually active ladies who do not have a monogamous relationship may also help reduce risk. "

According to researchers, it is estimated that between 2000 and 30 million women will use Depo Provera, its use is rapidly expanding in many developing countries with high sexuality rates. Oral contraceptives consist of long-acting hormones that are injected into the arms and buttocks four times a year.

Like all hormonal contraceptives, Depo Provera does not provide protection against sexually transmitted diseases (STD). Chlamydia and gonorrhea are the most common sexually transmitted diseases caused by bacteria and about 150 million new cases of Chlamydia and gonorrhea are reported worldwide each year. They cause many diseases including pelvic inflammatory diseases and infertility

This study, published in the September issue of sexually transmitted diseases, compared the effects of oral contraceptives and Depo Provera on the incidence of Chlamydia and gonorrhea in 819 women. Most women are single, 43% black, average 22 years old.

Women who use Depo Provera are 5 times more likely to develop STD than women who use hormone-free contraceptives

Researchers said the study did not determine how the use of Depo Provera increased the risk of having STD. But they say that contraceptives for injection can lower estrogen levels and increase susceptibility to vaginal and cervical infections.

Depo-Provera is a contraceptive, a hormone injection that lasts for 3 months. It prevents ovaries from releasing eggs by injecting synthetic progesterone. The effective interest rate of Depo-Provera is 99.7%. Some of the advantages of this contraceptive method are that it is private, effective after 24 hours, does not require frequent attention, does not interfere with sexual play, and reduces the risk of ovarian cancer and uterine cancer Sometimes. Nevertheless, Depo-Provera can cause sexually transmitted disease prevention, delayed recovery of fertility, weight gain and irregular bleeding (Cat Bytes, 1999).

Like all hormonal contraceptives, Depo Provera does not provide protection against sexually transmitted diseases (STD). Chlamydia and gonorrhea are the most common sexually transmitted diseases caused by bacteria and about 150 million new cases of Chlamydia and gonorrhea are reported worldwide each year. They cause many diseases including pelvic inflammatory diseases and infertility

Depo-Provera is a long-acting prescription contraceptive only containing hormone progesterone. It is administered by injection and is repeated every 12 weeks. Depo-Provera prevents your body from ovulating, thickens your cervical mucus, and makes pregnancy less prone. If contraceptives are injected within 5 days after the start of treatment, contraceptives will begin to exert full effect within 24 hours. However, when taking Depo-Provera within 5 days after shooting, please use condoms for one week after taking a picture for safety. Depo-Provera is a very effective contraceptive choice for women who have completed birth but do not want to dress of the fallopian tubes. This is also a good choice for women who can not use other forms of contraceptive devices for medical conditions or other forms of contraceptives.